Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
18 studies found for:    Vasculitis | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Not yet recruiting A Randomized Multicenter Study for Isolated Skin Vasculitis
Conditions: Primary Cutaneous Vasculitis;   Cutaneous Polyarteritis Nodosa;   IgA Vasculitis;   Henoch-Schönlein Purpura
Interventions: Drug: Colchicine;   Drug: Dapsone;   Drug: Azathioprine
2 Recruiting Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Conditions: Autoimmune Disease;   Vascular Disease
3 Recruiting The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
Conditions: Granulomatosis With Polyangiitis;   Wegener Granulomatosis;   Vasculitis
Interventions: Drug: 5 mg prednisone;   Drug: 0 mg prednisone
4 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
5 Recruiting Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis
Condition: Takayasu Arteritis
6 Recruiting The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
Condition: Granulomatosis With Polyangiitis
Interventions: Drug: Prednisone 5 mg/day;   Drug: Prednisone 0 mg/day
7 Recruiting Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis
Condition: Takayasu's Arteritis
8 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo
9 Recruiting PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Conditions: Cardiac Disease;   Dementia;   Inflammatory Disease;   Fever of Unknown Origin;   Vasculitis;   Osteomyelitis;   FDG Avid Cancers
Interventions: Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
10 Recruiting Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   Wegener's
11 Recruiting Determining Disease Activity Biomarkers in Individuals With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Conditions: Eosinophilic Granulomatosis With Polyangiitis;   Churg-Strauss Syndrome
12 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
13 Recruiting Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
Conditions: Healthy Volunteers;   Abnormal Phagocyte Function
14 Recruiting Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
Condition: Polyarteritis Nodosa
15 Recruiting Immunogenetic Mechanisms in Behcet's Disease
Conditions: Behcet's Disease;   Uveitis
16 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
17 Recruiting Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
18 Recruiting Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
Conditions: Autoimmune Disease;   Crohn Disease;   Inflammatory Disorder;   Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Takayasu Arteritis
Interventions: Procedure: Computed Tomography;   Radiation: Fluorine F 18 Clofarabine;   Procedure: Positron Emission Tomography

Indicates status has not been verified in more than two years